{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:36:48Z","timestamp":1790714208613,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CSL Centenary Fellowship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Australian National Health and Medical Research Council of Australia","award":["2025362"],"award-info":[{"award-number":["2025362"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["2008501"],"award-info":[{"award-number":["2008501"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Charles Darwin International Postgraduate Scholarship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,4,13]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Data on morbidity, mortality and cost for malaria-related hospitalisation are important for prioritising resources for malaria control strategies, but these data are often limited. The aim of this study was to understand the current malaria service delivery in Indonesia, including referral rates to hospitals, mortality outcomes and malaria-related costs at hospitals, using data from National Health Insurance claims.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were gathered from the recent Indonesian National Health Insurance dataset for claims made between 2015 and 2020. Cases were selected for any diagnosis with the international classification of diseases-10th revision codes for malaria-related diseases. Patients\u2019 sociodemographic status, repeated presentations to healthcare facilities, referral patterns and costs of treatment for the hospital settings were assessed by malaria species. Costs were reported in 2020 US$.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data were available for 12\u2009970 episodes of malaria, which occurred in 8833 patients.\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      accounted for 6019 (46.4%) episodes, and\n                      <jats:italic>P. vivax<\/jats:italic>\n                      for 4307 (33.2%) episodes. The incidence rates were 0.38 (95% CI 0.29 to 0.47) per person-years for\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      and 0.33 (95% CI 0.19 to 0.52) for\n                      <jats:italic>P. vivax<\/jats:italic>\n                      . 46% of malaria cases initially presented at the hospital. Among these patients, the mean cost was US$16.2 (SD 4.4) for an outpatient consultation and US$228.7 (SD 122.6) for inpatient care. In total, 4.8% (623) of patients re-presented to the hospital within 30 days of a malaria episode, of whom 1.7% (219) required admission for inpatient care, which was estimated to cost US$230.0 (SD 105.5). The risk of mortality for inpatients with\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      malaria was 2.1% (36\/1718) compared with 1.2% (16\/1359) for patients with\n                      <jats:italic>P. vivax<\/jats:italic>\n                      malaria; p=0.069.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The National Health Insurance claim data provide detailed costing estimates. Integrating data from the existing malaria information system with the data from the National Health Insurance claims can provide important insights into the healthcare costs associated with the management of malaria that could help optimise national antimalarial policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-018255","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:55:12Z","timestamp":1747065312000},"page":"e018255","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Malaria morbidity, mortality and associated costs in Indonesia: analysis of the National Health Insurance claim dataset"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-3663","authenticated-orcid":false,"given":"Ery","family":"Setiawan","sequence":"first","affiliation":[{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Health Administration and Policy, Universitas Indonesia, Depok, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-8706","authenticated-orcid":false,"given":"Angela","family":"Devine","sequence":"additional","affiliation":[{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health & Centre for Health Policy, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Dewi","family":"Prameswary","sequence":"additional","affiliation":[{"name":"National Malaria Program, Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Kevin","family":"Baird","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Oxford University, Central Jakarta, Indonesia"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-2874","authenticated-orcid":false,"given":"Ric","family":"Price","sequence":"additional","affiliation":[{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[{"name":"Division of Global and Tropical Health, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2025073013511634000_10.5.e018255.1","unstructured":"World Health Organization . WHO - SDG target 3.3 communicable disease. Geneva World Health Organization. Available: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/sdg-target-3_3-communicable-diseases"},{"key":"2025073013511634000_10.5.e018255.2","unstructured":"World Health Organization . World malaria report 2023. Licence: CC BY-NC-SA 3.0 IGO. Geneva World Health Organization; 2023."},{"key":"2025073013511634000_10.5.e018255.3","unstructured":"President regulation number 18\/2020 about mid term development plan. 2020."},{"key":"2025073013511634000_10.5.e018255.4","unstructured":"The Ministry of Health . Indonesia malaria annual report 2022. 2022."},{"key":"2025073013511634000_10.5.e018255.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-019-2760-8","article-title":"Social determinants of malaria in an endemic area of Indonesia","volume":"18","author":"Hasyim","year":"2019","journal-title":"Malar J"},{"key":"2025073013511634000_10.5.e018255.6","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v3i3.428","article-title":"Treatment-seeking behavior for malaria among communities in Indonesia: A systematic review","volume":"3","author":"Philothra","year":"2023","journal-title":"Narra J"},{"key":"2025073013511634000_10.5.e018255.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2009.02227.x"},{"key":"2025073013511634000_10.5.e018255.8","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.226688"},{"key":"2025073013511634000_10.5.e018255.9","unstructured":"DJSN . Monitoring and evaluation system: national social security council on national health insurance. 2024."},{"key":"2025073013511634000_10.5.e018255.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-07434-9","article-title":"Utilization patterns of healthcare facility and estimated expenditure of PLHIV care under the Indonesian National Health Insurance Scheme in 2018","volume":"22","author":"Setiawan","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2025073013511634000_10.5.e018255.11","unstructured":"The minister of health regulation no 3\/2023 on tariff setting of healthcare service delivery under the national health insurance scheme. Jakarta. Indonesia, 2023. Available: https:\/\/peraturan.bpk.go.id\/Details\/275518\/permenkes-no-3-tahun-2023"},{"key":"2025073013511634000_10.5.e018255.12","unstructured":"The Government of Indonesia . President regulation 82\/ 2018 regarding health insurance. Jakarta, 2018."},{"key":"2025073013511634000_10.5.e018255.13","unstructured":"Indonesian Ministry of Health . Guideline of malaria diagnosis and treatment. Jakarta - Indonesia, 2023. Available: https:\/\/malaria.kemkes.go.id\/sites\/default\/files\/2024-02\/X_Cetak%20Buku%20Saku%20talak%20Des%202023F.pdf [accessed 04 Oct 2024]"},{"key":"2025073013511634000_10.5.e018255.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m4075","article-title":"Gestational age and hospital admissions during childhood: population based, record linkage study in England (TIGAR study)","volume":"371","author":"Coathup","year":"2020","journal-title":"BMJ"},{"key":"2025073013511634000_10.5.e018255.15","doi-asserted-by":"publisher","DOI":"10.1177\/00469580231167011"},{"key":"2025073013511634000_10.5.e018255.16","doi-asserted-by":"publisher","DOI":"10.1007\/s12245-008-0061-z"},{"key":"2025073013511634000_10.5.e018255.17","unstructured":"Shreffler J , Huecker MR . Hypothesis testing, p values, confidence intervals, and significance. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557421\/#"},{"key":"2025073013511634000_10.5.e018255.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.03.021"},{"key":"2025073013511634000_10.5.e018255.19","unstructured":"2024. Available: https:\/\/www.icd10data.com\/ICD10CM\/Codes\/A00-B99\/B50-B64\/B54"},{"key":"2025073013511634000_10.5.e018255.20","unstructured":"World Health Organisation . WHO-choice unit cost estimates for service delivery. Geneva, Switzerland, 2011. Available: http:\/\/www.who.int\/choice\/cost-effectiveness\/inputs\/health_service\/en [accessed 02 Aug 2024]"},{"key":"2025073013511634000_10.5.e018255.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003614","article-title":"Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study","volume":"18","author":"Devine","year":"2021","journal-title":"PLoS Med"},{"key":"2025073013511634000_10.5.e018255.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008838","article-title":"The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia","volume":"14","author":"Thriemer","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025073013511634000_10.5.e018255.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002815","article-title":"Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study","volume":"16","author":"Kenangalem","year":"2019","journal-title":"PLoS Med"},{"key":"2025073013511634000_10.5.e018255.24","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20054581","article-title":"A Causal View of the Role and Potential Limitations of Capitation in Promoting Whole Health System Performance","volume":"20","author":"Matchar","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2025073013511634000_10.5.e018255.25","unstructured":"National Social Security Council . National health insurance (JKN) statistic. Jakarta, 2022. Available: https:\/\/djsn.go.id\/files\/dokumen\/Dokumen%20Kajian\/202212131425Buku%20Statistik%20JKN%202016-2021.pdf [accessed 19 Feb 2025]"},{"key":"2025073013511634000_10.5.e018255.26","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.75.783"},{"key":"2025073013511634000_10.5.e018255.27","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1588-8"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-018255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:51:26Z","timestamp":1753908686000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-018255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,12]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjgh-2024-018255"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-018255","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}